Price Alert

Anavex Life Sciences Corp... (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

9.91

-0.20 (-1.98%)

At close: Aug 15, 2025, 3:59 PM

10.26

3.48%

After-hours: Aug 15, 2025, 06:30 PM EDT

Anavex Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	101.16M	115.77M	120.78M	132.19M	138.76M	139.39M	143.76M	151.02M	154.82M	153.47M	143.62M	149.16M	153.2M	153.34M	151.15M	152.11M	157.56M	75.86M	47.36M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	89K	234K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-89K	n/a	n/a	3.36M	n/a	n/a	n/a	3.55B	n/a	n/a	n/a	9.51M	n/a	n/a	n/a
Receivables	820K	666K	2.56M	2.45M	1.72M	3.79M	3.55M	2.71M	2.17M	4.74M	4.09M	3.19M	6.56M	6.47M	5.37M	9.14M	8.6M	7.33M	6.58M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	-820K	702K	711K	931K	1.06M	1.34M	756K	653K	827.57K	981.77K	655.64K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	101.16M	117.14M	124.04M	135.57M	141.53M	144.52M	148.07M	154.39M	157.81M	159.19M	148.37M	152.7M	160.22M	160.28M	156.9M	161.62M	166.42M	83.57M	54.33M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	234K	n/a	3.36M	n/a	n/a	n/a	3.55B	n/a	n/a	n/a	9.51M	n/a	n/a	n/a
Total Assets	102.43M	117.14M	124.04M	135.57M	141.53M	144.75M	148.07M	154.39M	157.81M	159.19M	148.37M	152.7M	160.22M	160.28M	156.9M	161.62M	166.42M	83.57M	54.33M
Account Payables	6.74M	7M	4.57M	9.63M	3.5M	3.73M	4.29M	4.32M	4.15M	6.28M	5.29M	3.82M	3.13M	2.63M	4.63M	4.74M	4.18M	3.66M	4.22M
Deferred Revenue	805K	829K	829K	842K	917K	917K	917K	917K	916.76K	916.76K	916.76K	443.83K	443.83K	443.83K	443.83K	443.83K	443.83K	487.11K	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	-1.19M	2.2M	2.02M	1.53M	1.03M	n/a	n/a	n/a	916.76K	1.57M	916.76K	5.09M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	7.54M	17.38M	13.13M	15.3M	11.75M	9.56M	12.49M	12.53M	11.06M	14.02M	13.25M	10.21M	9.48M	8.07M	10.53M	10.8M	9.27M	7.76M	8.03M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.93M	9.55M	7.73M	4.83M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	3.93M	9.55M	7.73M	4.83M	n/a	4.92M	7.29M	7.29M	5.99B	n/a	7.04M	4.27M	5.91M	3.08M	5.08M	5.61M	n/a	3.62M	3.82M
Total Liabilities	11.47M	17.38M	13.13M	15.3M	11.75M	9.56M	12.49M	12.53M	11.06M	14.02M	13.25M	10.21M	9.48M	8.07M	10.53M	10.8M	9.27M	7.76M	8.03M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	85K	85K	85K	85K	85K	84K	82K	82K	81.39K	80.24K	78.03K	77.94K	77.94K	77.16K	76.16K	75.92K	75.15K	70.03K	66.96K
Retained Earnings	-372.62M	-359.38M	-348.18M	-336.07M	-324.45M	-312.24M	-301.69M	-293.07M	-282.92M	-271.64M	-258.54M	-245.56M	-231.27M	-218.91M	-208.47M	-197.59M	-185.87M	-175.69M	-167.53M
Comprehensive Income	n/a	n/a	n/a	n/a	-89K	-234K	n/a	n/a	n/a	n/a	n/a	0.00	0.00	-403.7K	0.00	-0.00	-0.00	251.5M	n/a
Shareholders Equity	90.96M	99.76M	110.92M	120.26M	129.78M	135.19M	135.57M	141.85M	146.75M	145.17M	135.12M	142.49M	150.74M	152.21M	146.37M	150.82M	157.15M	75.81M	46.3M
Total Investments	n/a	n/a	n/a	n/a	89K	234K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a